19 Juli 2021
Grafik 1. Rata-rata Berjalan Penambahan Jumlah Orang Grafik 2. Nilai Penjualan Ritel di Amerika Serikat dan
Menerima Vaksin per 7 Hari Cina
900000 600 5000
800000
Suku 500
Produk 700000 4000
Bunga 600000 400
Milyar RMB
Milyar USD
3000
SMFP05ACN5 4,75 500000
300
400000
2000
SMFP05BCN5 5,75 300000 200
200000
1000
SMSMFP01CN3 4,75 100000 100
0
0 0
SMFP10XXMS 5,25
Mar-19
May-19
Jul-19
Sep-19
Nov-19
Jan-20
Mar-20
May-20
Jul-20
Sep-20
Nov-20
Jan-21
Mar-21
May-21
1
1
2
2
20
20
20
20
20
20
2/
3/
4/
5/
6/
7/
6/
6/
6/
6/
6/
6/
Dosis ke-1 Dosis ke-2 Amerika Serikat Cina
20
0
1
2
2
0
20
20
20
20
20
20
20
20
20
/2
1/
3/
5/
7/
9/
1/
3/
5/
7/
11
2/
2/
2/
2/
2/
2/
2/
2/
2/
2/
Ekspetasi Situasi Sekarang IKK IndONIA BI 7DRR
1
20
0
1
0
1
20
21
20
0
1
20
0
1
0
1
20
21
20
-2
-2
l-2
l-2
-2
-2
-2
-2
l-2
l-2
-2
-2
Finansial (Persero)
v-
n-
n-
p-
v-
n-
n-
p-
ar
ar
ay
ay
ar
ar
ay
ay
Ju
Ju
Ju
Ju
No
No
Ja
Ja
Se
Ja
Ja
Se
M
M
M
M
Grha SMF Obligasi RI Spread Obligasi AS Bank Institusi pemerintah Reksa dana Individual Lainnya Asing
5600 100 3
DPK OMO
5400 0
2
Jan-20
Feb-20
Mar-20
Apr-20
May-20
Jun-20
Jul-20
Aug-20
Sep-20
Oct-20
Nov-20
Dec-20
Jan-21
Feb-21
Mar-21
Apr-21
1 tahun 5 tahun n n n
10 tahu 15 tahu 20 tahu
Jakarta 12160
Telp. + 62 21 2700400
Fax. + 62 21 2701400 Disclaimer:
The information contained in this report has been taken from sources which we deem reliable. However, none of any PT Sarana Multigriya
Finansial (Persero) and/or their respective employees and/or agents make any representation or warranty (express or implied) or accepts
info@smf-indonesia.co.id any responsibility or liability as to, or in relation to, the accuracy or completeness of the information and opinions contained in this report or
as to any information contained in this report or any other such information or opinions remaining unchanged after the issue thereof. We
www.smf-indonesia.co.id expressly disclaim any responsibility or liability (express or implied) of PT Sarana Multigriya Finansial (Persero) employees and agents
whatsoever and howsoever arising (including, without limitation for any claims, proceedings, action, suits, losses, expenses, damages or
costs) which may be brought against or suffered by any person as a result of acting in reliance upon the whole or any part of the contents of
this report. For further information please contact our number +6221-2700 400.